A new pleuromutilin candidate with potent antibacterial activity against Pasteurella multocida

Yunxing Fu1, Lijun Ma2, Yunpeng Yi1

  • 1Key Laboratory of New Animal Drug Project of Gansu Province, Key Laboratory of Veterinary Pharmaceutical Development, Ministry of Agriculture, PR China; Lanzhou Institute of Husbandry and Pharmaceutical Sciences of CAAS, Lanzhou, 730050, China.

Microbial Pathogenesis
|December 12, 2018
PubMed

Insights

The novel antimicrobial 14-O-[(4,6-Diaminopyrimidine-2-yl) thioacetyl] mutilin (DPTM) shows potent activity against Pasteurella multocida serotype A. DPTM effectively reduced bacterial load and mortality in a lung infection model.

Area of Science:

  • Veterinary Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Pasteurella multocida is a significant pathogen causing respiratory infections in animals.
  • Novel antimicrobial agents are needed to combat bacterial infections, including those caused by P. multocida.

Purpose of the Study:

  • To evaluate the in vitro and in vivo antimicrobial activity of 14-O-[(4,6-Diaminopyrimidine-2-yl) thioacetyl] mutilin (DPTM) against Pasteurella multocida serotype A.

Main Methods:

  • Minimum Inhibitory Concentration (MIC) assays were performed to determine the lowest concentration of DPTM inhibiting bacterial growth.
  • Oxford Cup assays measured the zone of inhibition produced by DPTM.
  • Time-kill experiments assessed the rate of bacterial killing by DPTM.
  • A mouse lung infection model was used to evaluate DPTM's efficacy in vivo.

Main Results:

  • DPTM demonstrated potent in vitro activity against P. multocida serotype A, with a MIC of 0.781 μg/mL.
  • Significant inhibition zones were observed in Oxford Cup assays.
  • Time-kill experiments showed a rapid reduction in bacterial numbers, with 94.6% killing within 24 hours.
  • In vivo, DPTM significantly reduced mortality, bacterial load, and lung pathology in a P. multocida-induced pneumonia model.

Conclusions:

  • DPTM exhibits significant antimicrobial activity against Pasteurella multocida serotype A.
  • DPTM shows promise as a therapeutic agent for controlling or preventing P. multocida-associated pneumonia.

Related Concept Videos

Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
8.6K
tRNA Activation02:26

tRNA Activation

Aminoacyl-tRNA synthetases are present in both eukaryotes and bacteria. Though eukaryotes have 20 different aminoacyl-tRNA synthetases to couple to 20 amino acids, many bacteria do not have genes for all of these aminoacyl-tRNA synthetases. Despite this, they still use all 20 amino acids to synthesize their proteins. For instance, some bacteria do not have the gene encoding the enzyme that couples glutamine with its partner tRNA. In these organisms, one enzyme adds glutamic acid to all of the...
22.9K
Activation Energy01:26

Activation Energy

Activation energy is the minimum amount of energy necessary for a chemical reaction to move forward. The higher the activation energy, the slower the rate of the reaction. However, adding heat to the reaction will increase the rate, since it causes molecules to move faster and increase the likelihood that molecules will collide. The collision and breaking of bonds represents the uphill phase of a reaction and generates the transition state. The transition state is an unstable high-energy state...
86.6K
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
12.8K
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
137.8K
Primary Active Transport01:47

Primary Active Transport

In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
198.3K